🏢 Brand Settlements
Valsartan, Losartan, Irbesartan Class Action Settlements — 2 Active Cases
SettlementRadar is not affiliated with, endorsed by, or connected to Valsartan, Losartan, Irbesartan. This page provides independent information about class action settlements involving this company.
2 no-proof settlements — file with no documentation required. Deadlines are approaching. Check eligibility now.
⚖️
2
Active Cases
✅
2
No Proof Required
📅
56d
Nearest Deadline
Open Valsartan, Losartan, Irbesartan Settlements
✓ No Proof Required
Consumer
⏳ 56 days left
🟢 Easy
Valsartan, Losartan, Irbesartan
You may be included in this settlement if you paid for Hetero Valsartan, Aurobindo Irbesartan, or Vivimed Losartan medications between January 1, 2016 and the present.
Who qualifies: You may be included in this settlement if you paid for Hetero Valsartan, Aurobindo Irbesartan, or Vivimed Losartan medications between January 1, 2016
✓ No Proof Required
Healthcare
⏳ 56 days left
🟢 Easy
Hetero Valsartan $11.37M Drug Contamination Settlement
Consumers who bought Hetero Valsartan between May 1, 2018, and July 31, 2018, may be eligible to claim a cash payment from a class action settlement.
Who qualifies: Class members must meet all of the following criteria: They are an individual in the United States, its territories or possessions. They paid any amou
$11,370,000
Total settlement fund
